BNTC
BNTC
NASDAQ · Biotechnology

Benitec Biopharma Inc

$11.19
+0.21 (+1.91%)
As of Mar 23, 10:06 PM ET ·
Financial Highlights (FY 2025)
Revenue
792.56M
Net Income
29.18M
Gross Margin
63.0%
Profit Margin
3.7%
Rev Growth
+7.9%
D/E Ratio
0.15
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 63.0% 63.0% 63.0%
Operating Margin 3.1% 3.5% 3.5%
Profit Margin 3.7% 3.0% 2.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 792.56M 838.23M 726.24M
Gross Profit 499.53M 528.32M 457.73M
Operating Income 24.81M 29.24M 25.14M
Net Income 29.18M 25.09M 21.12M
Gross Margin 63.0% 63.0% 63.0%
Operating Margin 3.1% 3.5% 3.5%
Profit Margin 3.7% 3.0% 2.9%
Rev Growth +7.9% +14.3% -7.3%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 36.97M 45.09M 45.44M
Total Equity 251.07M 287.18M 287.83M
D/E Ratio 0.15 0.16 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 33.32M 33.92M 33.30M
Free Cash Flow 24.79M 28.65M 30.31M